Trade Harvard Bioscience - HBIO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0147 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.1728 |
| Open | 1.0728 |
| 1-Year Change | -74.93% |
| Day's Range | 0.9628 - 1.0728 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 0.9740 | -0.1288 | -11.68% | 1.1028 | 1.1128 | 0.9361 |
| Feb 20, 2025 | 1.1728 | -0.0500 | -4.09% | 1.2228 | 1.2528 | 1.1528 |
| Feb 19, 2025 | 1.2328 | -0.0300 | -2.38% | 1.2628 | 1.2628 | 1.2128 |
| Feb 18, 2025 | 1.2728 | -0.0700 | -5.21% | 1.3428 | 1.3628 | 1.2728 |
| Feb 14, 2025 | 1.3328 | 0.0100 | 0.76% | 1.3228 | 1.4228 | 1.3228 |
| Feb 13, 2025 | 1.3228 | 0.0600 | 4.75% | 1.2628 | 1.3228 | 1.2528 |
| Feb 12, 2025 | 1.3028 | -0.0200 | -1.51% | 1.3228 | 1.3628 | 1.2528 |
| Feb 11, 2025 | 1.3328 | -0.0700 | -4.99% | 1.4028 | 1.4028 | 1.3228 |
| Feb 10, 2025 | 1.4028 | -0.0200 | -1.41% | 1.4228 | 1.4528 | 1.3728 |
| Feb 7, 2025 | 1.4328 | -0.0200 | -1.38% | 1.4528 | 1.5028 | 1.4228 |
| Feb 6, 2025 | 1.4728 | -0.1800 | -10.89% | 1.6528 | 1.6628 | 1.4528 |
| Feb 5, 2025 | 1.6528 | 0.0200 | 1.22% | 1.6328 | 1.6728 | 1.6228 |
| Feb 4, 2025 | 1.6628 | 0.0400 | 2.46% | 1.6228 | 1.6828 | 1.6228 |
| Feb 3, 2025 | 1.6328 | -0.0500 | -2.97% | 1.6828 | 1.6828 | 1.6128 |
| Jan 31, 2025 | 1.7028 | -0.0700 | -3.95% | 1.7728 | 1.7728 | 1.6928 |
| Jan 30, 2025 | 1.7528 | 0.0100 | 0.57% | 1.7428 | 1.8028 | 1.7028 |
| Jan 29, 2025 | 1.7328 | 0.0400 | 2.36% | 1.6928 | 1.7628 | 1.6728 |
| Jan 28, 2025 | 1.6928 | -0.0500 | -2.87% | 1.7428 | 1.7828 | 1.6928 |
| Jan 27, 2025 | 1.7928 | 0.0400 | 2.28% | 1.7528 | 1.8228 | 1.7528 |
| Jan 24, 2025 | 1.7328 | -0.0800 | -4.41% | 1.8128 | 1.8128 | 1.7228 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Harvard Bioscience Company profile
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a developer, manufacturer, and seller of technologies, products and services that enable fundamental research, discovery, and preclinical testing for drug development. The Company provides products that support research in six different classes of laboratory use, including molecular, cellular, tissue, organ, organisms, and clinical. The Company primarily sells its products under several brand names, including Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS. The Company’s customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs, and government researchers.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Harvard Bioscience, Inc. revenues increased 16% to $118.9M. Net loss decreased 96% to $288K. Revenues reflect United States segment increase of 18% to $49.8M, Europe segment increase of 19% to $35.8M. Lower net loss reflects Interest expense decrease of 68% to $1.5M (expense), G/L on early Exting of lease relat debt decrease from $1.9M (expense) to $0K.
Equity composition
Common Stock $.01 Par, 12/10, 80M auth., 36,057,974 issd., less 7,745,507 shs. in Treas. @ 10.7M. Insiders & Strategic holders own 13.56%. IPO: 12/7/2000, 6,420,000 shs. @$8 by Thomas Weisel Partners LLC. *NOTE: 10/02, Company acquired Genomic Solutions, Inc. @ 0.1017 shares and $0.286 in cash (3,178,857 shares issd.).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
84 October Hill Rd
HOLLISTON
MASSACHUSETTS 01746-1371
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com